Comparison of Cerebral SctO2 Between 36℃ and 33℃ of TTM After Cardiac Arrest
Primary Purpose
Heart Arrest
Status
Unknown status
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Arctic Sun
Sponsored by
About this trial
This is an interventional other trial for Heart Arrest focused on measuring Temperature, Hypothermia, Brain, Oxygen, Prognosis
Eligibility Criteria
Inclusion Criteria:
- Comatose patients successfully resuscitated from cardiac arrest
Exclusion Criteria:
- < 18 years old
- Definite non-cardiac cause arrest
- Contraindication to TH Active bleeding, coagulopathy, fatal arrhythmia, severe infectious condition
- Presence of advanced directives to withhold or withdraw life-sustaining treatment
- Expected survival < 72 hours
- Underlying low CPC (≤ 3)
- No informed consent
- Follow-up loss
Sites / Locations
- Seoul National University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
36-TH
33-TH
Arm Description
Core temperature 36℃ of targeted temperature management (36-TH) for 24 hours in cardiac arrest victims using Arctic Sun.
Core temperature 33℃ of targeted temperature management (36-TH) for 24 hours in cardiac arrest victims using Arctic Sun.
Outcomes
Primary Outcome Measures
The comparison of the 72-hour SctO2 level between the 36-TH and 33-TH groups in cardiac arrest victims
Secondary Outcome Measures
The comparison of the 72-hour changes in SctO2 level between the 36-TH and 33-TH groups
The comparison of the severity scores between the 36-TH and 33-TH groups
APACHE II score
Sequential Organ Failure Assessment (SOFA) score
The comparison of the serum biomarker levels between the 36-TH and 33-TH groups
Neuron specific enolase
Cytokines
Antioxidants
The comparison of the number of patients with survival discharge between the 36-TH and 33-TH groups
The comparison of the 6-month cerebral performance scale (CPC) between the 36-TH and 33-TH groups
Complication of therapeutic hypothermia
Bleeding requiring transfusion
Fatal arrhythmia requiring intervention
Electrolyte imbalance: newly developed abnormal values
Hyper/hypoglycemia
Sepsis/pneumonia
Full Information
NCT ID
NCT02889744
First Posted
August 18, 2016
Last Updated
March 16, 2021
Sponsor
Seoul National University Hospital
Collaborators
Bard Ltd
1. Study Identification
Unique Protocol Identification Number
NCT02889744
Brief Title
Comparison of Cerebral SctO2 Between 36℃ and 33℃ of TTM After Cardiac Arrest
Official Title
Comparison of Cerebral Tissue Oxygen Saturation (SctO2) Between 36℃ and 33℃ of Targeted Temperature Management (TTM) After Cardiac Arrest
Study Type
Interventional
2. Study Status
Record Verification Date
March 2021
Overall Recruitment Status
Unknown status
Study Start Date
March 2016 (undefined)
Primary Completion Date
July 2020 (Actual)
Study Completion Date
March 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Seoul National University Hospital
Collaborators
Bard Ltd
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The investigators hypothesize that
if decrease in SctO2 level is caused by the degree of hypothermia, SctO2 level in the 33-TH may be lower than that in the 36-TH group.
if decrease in SctO2 level is not caused by the degree of hypothermia but caused by brain injury, SctO2 level may be associated with only the prognosis of cardiac arrest victims regardless of core temperatures.
The primary objective of this study is to compare the 72-hour changes in SctO2 level between the 36-TH and 33-TH groups in cardiac arrest victims.
Detailed Description
Subject Identification and Screening For each cohort, patients will be identified after acquisition of sustained return of spontaneous circulation (ROSC) (> 30 minutes). If the patients meet inclusion/exclusion criteria, patients will be enrolled in the study. The investigators will obtain written informed consent from all of the patients or their representatives.
Assignment of Subject Number A unique identification number will be given to study subjects in an attempt to de-identify their information. Subject numbers will be assigned in sequential order. The subject number will consist of four digits. The first two digits will designate the study site. The last two digits will designate the subject by number in sequential order (i.e., subject number 01 01 will be the first subject at site 1; 01 02 will be the second subject at site 1, etc.).
Study Methods
Randomization to 36-TH (core body temperature (BT) 36℃) or 33-TH (core BT 33℃) group will be performed by a web based randomization site (http://mrcc.snuh.org).
Start target temperature management using external cooling device (Arctic Sun) within 1 hour post-ROSC.
SctO2 monitoring starts within 1 hour post-ROSC and maintain for 72 hours.
36-TH (core BT 36℃) or 33-TH (core BT 33℃) for 24 hours
Rewarming 0.25℃/h in 33-TH group
Core temperature < 37.5℃ for 72 hours
All patients will be treated per the postresuscitation care protocol. Target treatment will include
Target: central venous pressure (CVP) (8 - 12 mmHg), mean arterial pressure (MAP) (> 65 mmHg), central venous oxygen saturation (ScvO2) (> 70%)
Seizure control, shivering control as appropriate
Coronary intervention as soon as possible if needed
Infection control if indicated
Other supportive care
Monitoring data including
CVP, MAP, ScvO2, lactate, neuron specific enolase (NSE), end-tidal carbon dioxide (EtCO2), input-output (I/O) balance
Intermittent electroencephalography (EEG) monitoring (2 times/72 hours)
Laboratory data including arterial blood gas analysis (ABGA), complete blood count (CBC), liver function test (LFT), electrolyte, blood urea nitrogen/creatinine (BUN/Cr), et al.
SctO2
Core (esophageal or bladder) temperature
Data Collection
Study data will be collected in the following manner:
• All data will be collected on appropriate Case Report Forms.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Arrest
Keywords
Temperature, Hypothermia, Brain, Oxygen, Prognosis
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
From the results of previous studies, we assumed that the mean difference in rSO2 at 72 h between the 36℃ or 33℃ groups would be 3% with 4% of standard deviation. By a referral (2015-0207) to the Medical Research Collaborating Center (MRCC) of SNUH/SNUMC, a sample size of at least 58 (29 per group) was calculated with a power of 0.8 and a significance level of 0.05. Considering an unexpected loss of 15%, the study was planned for 66 participants.
Randomization was performed by the 4, 6-block randomization method at the MRCC SNUH/SNUMC web-site (http://mrcc.snu.ac.kr).
Masking
Outcomes Assessor
Masking Description
Primary and secondary outcomes were assessed by an investigator blinded to this study.
Allocation
Randomized
Enrollment
66 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
36-TH
Arm Type
Active Comparator
Arm Description
Core temperature 36℃ of targeted temperature management (36-TH) for 24 hours in cardiac arrest victims using Arctic Sun.
Arm Title
33-TH
Arm Type
Active Comparator
Arm Description
Core temperature 33℃ of targeted temperature management (36-TH) for 24 hours in cardiac arrest victims using Arctic Sun.
Intervention Type
Device
Intervention Name(s)
Arctic Sun
Other Intervention Name(s)
External cooling device
Intervention Description
Targeted temperature management for 24 hours with core temperature 36℃ or 33℃
Primary Outcome Measure Information:
Title
The comparison of the 72-hour SctO2 level between the 36-TH and 33-TH groups in cardiac arrest victims
Time Frame
72 hour
Secondary Outcome Measure Information:
Title
The comparison of the 72-hour changes in SctO2 level between the 36-TH and 33-TH groups
Time Frame
0, 24, and 72 hours
Title
The comparison of the severity scores between the 36-TH and 33-TH groups
Description
APACHE II score
Sequential Organ Failure Assessment (SOFA) score
Time Frame
0, 24, and 72 hours
Title
The comparison of the serum biomarker levels between the 36-TH and 33-TH groups
Description
Neuron specific enolase
Cytokines
Antioxidants
Time Frame
0, 24, and 72 hours
Title
The comparison of the number of patients with survival discharge between the 36-TH and 33-TH groups
Time Frame
6 months
Title
The comparison of the 6-month cerebral performance scale (CPC) between the 36-TH and 33-TH groups
Time Frame
6 months
Title
Complication of therapeutic hypothermia
Description
Bleeding requiring transfusion
Fatal arrhythmia requiring intervention
Electrolyte imbalance: newly developed abnormal values
Hyper/hypoglycemia
Sepsis/pneumonia
Time Frame
72 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Comatose patients successfully resuscitated from cardiac arrest
Exclusion Criteria:
< 18 years old
Definite non-cardiac cause arrest
Contraindication to TH Active bleeding, coagulopathy, fatal arrhythmia, severe infectious condition
Presence of advanced directives to withhold or withdraw life-sustaining treatment
Expected survival < 72 hours
Underlying low CPC (≤ 3)
No informed consent
Follow-up loss
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gil Joon Suh, MD, PhD
Organizational Affiliation
Seoul National Univerisity College of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Seoul National University Hospital
City
Seoul
ZIP/Postal Code
03080
Country
Korea, Republic of
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
11856793
Citation
Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002 Feb 21;346(8):549-56. doi: 10.1056/NEJMoa012689. Erratum In: N Engl J Med 2002 May 30;346(22):1756.
Results Reference
background
PubMed Identifier
24237006
Citation
Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wise MP, Aneman A, Al-Subaie N, Boesgaard S, Bro-Jeppesen J, Brunetti I, Bugge JF, Hingston CD, Juffermans NP, Koopmans M, Kober L, Langorgen J, Lilja G, Moller JE, Rundgren M, Rylander C, Smid O, Werer C, Winkel P, Friberg H; TTM Trial Investigators. Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med. 2013 Dec 5;369(23):2197-206. doi: 10.1056/NEJMoa1310519. Epub 2013 Nov 17.
Results Reference
background
PubMed Identifier
9505736
Citation
Buunk G, van der Hoeven JG, Meinders AE. A comparison of near-infrared spectroscopy and jugular bulb oximetry in comatose patients resuscitated from a cardiac arrest. Anaesthesia. 1998 Jan;53(1):13-9. doi: 10.1111/j.1365-2044.1998.00263.x.
Results Reference
result
PubMed Identifier
22521725
Citation
Suffoletto B, Kristan J, Rittenberger JC, Guyette F, Hostler D, Callaway C. Near-infrared spectroscopy in post-cardiac arrest patients undergoing therapeutic hypothermia. Resuscitation. 2012 Aug;83(8):986-90. doi: 10.1016/j.resuscitation.2012.03.021. Epub 2012 Apr 19.
Results Reference
result
PubMed Identifier
23313422
Citation
Meex I, Dens J, Jans F, Boer W, Vanhengel K, Vundelinckx G, Heylen R, De Deyne C. Cerebral tissue oxygen saturation during therapeutic hypothermia in post-cardiac arrest patients. Resuscitation. 2013 Jun;84(6):788-93. doi: 10.1016/j.resuscitation.2013.01.003. Epub 2013 Jan 8.
Results Reference
result
Learn more about this trial
Comparison of Cerebral SctO2 Between 36℃ and 33℃ of TTM After Cardiac Arrest
We'll reach out to this number within 24 hrs